Huang et al.99
|
PEG-Sn-ONc |
900, 944 |
PA |
Blood circulation (brain) |
• Absorbance shift from 860 nm to 930 nm via Tin chelation |
• Prolonged circulation time via axial PEGylation |
Zhou et al.78
|
P-Pc |
1064 |
PA |
Tumor imaging, GI tract |
• High absorbance (>1000) at 1000 nm |
• Imaging depth: 11.6 cm (chicken breast tissues), 5 cm (human arm) |
Lee et al.117
|
2,11,20,29,tetra-tert-butyl-2,3-Nc or 5,9,14,18,23,27,32,36-octabutoxy,-2,3-Nc |
707, 860 |
PA |
Lymphatic system imaging |
• Dual-color PA imaging of two separate lymphatic systems |
• Spectrally stable at a very high concentration |
Li et al.116
|
PF NP |
680 |
PA/FL |
Bimodal image-guided PTT/PDT |
• Switchable PTT+PA and PDT+FL theranostics |
• Highly selective for biotin receptor-positive cancer cells (e.g. A549) |
Choi et al.70
|
Nc/PFH@PCPN |
850 |
PA/US |
Bimodal image-guide HIFU therapy |
• 0 US imaging contrast when vaporized under HIFU ablation |
Wang et al.120
|
Fe3O4@PB @PDA/AlPc/BSA |
660 |
PA/FL/MR |
Trimodal image-guided PTT/PDT |
• Fe3O4-based MR contrast |
• Prussian blue (PB) modification for PA-guided PTT |
• Synergistic FL-guided PDT with AlPc photosensitizer |
Zhang et al.91
|
Surfactant-stripped ONc nanonap |
860 |
PA/PET |
Lymphatic mapping, tumor imaging |
• 64Cu-based PET contrast |